Search

Current filters:



Use filters to refine the search results.

Results 1-10 of 38 (Search time: 0.008 seconds).
Item hits:
PreviewIssue dateOnline publication dateTitleAuthor(s)
59893.pdf.jpg202030-Jun-2020Risk prediction in intrahepatic cholangiocarcinoma : direct comparison of the MEGNA score and the 8th edition of the UICC/AJCC cancer staging systemHahn, Felix; Müller, Lukas; Mähringer-Kunz, Aline; Schotten, Sebastian; Düber, Christoph; Hinrichs, Jan B.; Maschke, Sabine K.; Galle, Peter R.; Bartsch, Fabian; Lang, Hauke; Weinmann, Arndt; Kloeckner, Roman
diabetic_liver_injury_from_st-20220913193459567.pdf.jpg201314-Sep-2022Diabetic liver injury from streptozotocin is regulated through the caspase-8 homolog cFLIP involving activation of JNK2 and intrahepatic immunocompetent cellsKohl, Tobias; Gehrke, Nadine; Schad, Arno; Nagel, Michael; Wörns, Marcus-Alexander; Sprinzl, Martin; Zimmermann, Tim; He, You Wen; Galle, Peter R.; Schuchmann, Marcus; Schattenberg, Jörn
efficacy_and_safety_of_a_conv-20220714111608576.pdf.jpg201515-Jul-2022Efficacy and safety of a conversion from the original tacrolimus and mycophenolate mofetil to the generics Tacpan® and Mowel® after liver transplantationVollmar, Johanna; Bellmann, Maren Christina; Darstein, Felix; Hoppe-Lotichius, Maria; Mittler, Jens; Heise, Michael; Rüttger, Bernd; Weyer, Veronika; Zimmermann, Anca; Lang, Hauke; Galle, Peter R.; Zimmermann, Tim
59415.pdf.jpg201911-Nov-2019Cardiovascular risk categories in patients with nonalcoholic fatty liver disease and the role of low-density lipoprotein cholesterolLabenz, Christian; Prochaska, Jürgen H.; Huber, Yvonne; Nagel, Michael; Straub, Beate; Wild, Philipp; Galle, Peter R.; Schattenberg, Jörn
58508.pdf.jpg201817-Oct-2018The immune contexture of hepatocellular carcinoma predicts clinical outcomeFoerster, Friedrich; Hess, Moritz; Gerhold-Ay, Aslihan; Marquardt, Jens; Becker, Diana; Galle, Peter R.; Schuppan, Detlef; Binder, Harald; Bockamp, Ernesto
58506.pdf.jpg201817-Oct-2018Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinomaMähringer-Kunz, Aline; Weinmann, Arndt; Schmidtmann, Irene; Koch, Sandra; Schotten, Sebastian; Pinto dos Santos, Daniel; Pitton, Michael B.; Düber, Christoph; Galle, Peter R.; Klöckner, Roman
hepatic_interleukin1_receptor-20230131122849445.pdf.jpg202213-Feb-2023Hepatic interleukin-1 receptor type 1 signalling regulates insulin sensitivity in the early phases of nonalcoholic fatty liver diseaseGehrke, Nadine; Hofmann, Lea J.; Straub, Beate K.; Rühle, Frank; Waisman, Ari; Galle, Peter R.; Schattenberg, Jörn M.
continued_alcohol_consumption-20230202103201681.pdf.jpg20222-Feb-2023Continued alcohol consumption and hepatic encephalopathy determine quality of life and psychosocial burden of caregivers in patients with liver cirrhosisNagel, Michael; Weidner, Vanessa; Schulz, Sina; Marquardt, Jens U.; Galle, Peter R.; Scahttenberg, Jörn M.; Nguyen-Tat, Marc; Wörns, Marcus-Alexander; Labenz, Christian
pathogenic_lipidbinding_antip-20220902174134868.pdf.jpg202112-Sep-2022Pathogenic lipid-binding antiphospholipid antibodies are associated with severity of COVID-19Hollerbach, Anne; Müller-Calleja, Nadine; Pedrosa, Denise; Canisius, Antje; Sprinzl, Martin F.; Falter, Tanja; Rossmann, Heidi; Bodenstein, Marc; Werner, Christian; Sagoschen, Ingo; Münzel, Thomas; Schreiner, Oliver; Sivanathan, Visvakanth; Reuter, Michael; Niermann, Johannes; Galle, Peter R.; Teyton, Luc; Ruf, Wolfram; Lackner, Karl J.
ramucirumab_in_patients_with_-20220902173054571.pdf.jpg20217-Sep-2022Ramucirumab in patients with previously treated advanced hepatocellular carcinoma : impact of liver disease aetiologyGalle, Peter R.; Kudo, Masatoshi; Llovet, Josep M.; Finn, Richard S.; Karwal, Mark; Pezet, Denis; Kim, Tae-You; Yang, Tsai-Sheng; Lonardi, Sara; Tomasek, Jiri; Phelip, Jean-Marc; Touchefeu, Yann; Koh, Su-Jin; Stirnimann, Guido; Liang, Kun; Ogburn, Kenyon D.; Wang, Chunxiao; Abada, Paolo; Widau, Ryan C.; Zhu, Andrew X.